BioPharma Clinical Trials
AstraZeneca’s TAGRISSO® Shows Significant Improvement in Progression-Free Survival in Phase III LAURA Trial for EGFR-Mutated NSCLC
Positive results from the LAURA Phase III trial showed AstraZeneca’s TAGRISSO® (osimertinib) demonstrated a statistically significant a...
June 03, 2024 | News
EMA CHMP Recommends Approval of Sugemalimab for First-Line Treatment of NSCLC
EMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and ...
June 03, 2024 | News
Fortrea Launches Comprehensive Solution to Enhance Diversity and Inclusion in Clinical Trials
Fortrea, a leading global contract research organization (CRO), today announced its comprehensive and integrated solution to improve the diversity an...
May 31, 2024 | News
Kexing Biopharm’s Subsidiary Receives Approval for Clinical Trials of Innovative GB08 Growth Hormone
Kexing Biopharm announced that Shenzhen Kexing Pharmaceutical Co., Ltd., its wholly-owned subsidiary, recently received a Notice of Approval for Drug Clini...
May 31, 2024 | News
HanAll Biopharma Secures Exclusive Rights to Cutting-Edge Aging Reprogramming Technology
Exclusive agreement allows HanAll to utilize Epigenetic Reprogramming of Aging (ERATM) technology for ophthalmic and otic diseases. Collaboration aims t...
May 29, 2024 | News
Innovent Biologics Announces Phase 3 Success for Picankibart in Treating Moderate to SevereInnovent Biologics Announces Phase 3 Success for Picankibart in Treating Moderate to Severe Plaque Psoriasis
Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of canc...
May 28, 2024 | News
Neuren Pharmaceuticals Announces Positive Phase 2 Trial Results for NNZ-2591 in Pitt Hopkins Syndrome
Neuren Pharmaceuticals revealed top-line results from its Phase 2 clinical trial of NNZ-2591 in children with Pitt Hopkins syndrome (PTHS). This trial demo...
May 28, 2024 | News
Henlius Biotech and Organon Receive EMA Validation for Denosumab Biosimilar HLX14
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the marketing autho...
May 27, 2024 | News
Tyligand Bioscience Doses First Patient in Phase 1/2 Trial for Innovative KRAS G12D Cancer Therapy
Tyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies, announced that the fir...
May 27, 2024 | News
Telix Pharmaceuticals Submits NDA for Innovative Prostate Cancer Imaging Kit to FDA
Telix Pharmaceuticals announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA...
May 27, 2024 | News
Laekna Receives FDA Approval for Phase III Trial of Innovative mCRPC Treatment
Laekna, Inc. (2105.HK), a science-driven, clinical-stage biotechnology company, announced that the company has received approval from the U.S. Food an...
May 24, 2024 | News
GCCL Introduces First ddPCR Device in South Korea for Enhanced Clinical Trial Sample Analysis
Introduced the first ddPCR device in Korea to provide high-quality clinical trial sample analysis services by increasing test accuracy Differentiate glo...
May 23, 2024 | News
GC Biopharma and Novel Pharma Receive FDA IND Approval for MPS IIIA Treatment 'GC1130A'
GC Biopharma and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval. With this appr...
May 21, 2024 | News
Telix Pharmaceuticals' CUPID Study Demonstrates Promising Results for Next-Generation Prostate Cancer Therapy
CUPID is a Phase I safety and dosimetry study of TLX592, Telix's investigational antibody-based targeted alpha therapy for prostate cancer. Establishes ...
May 21, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
